Strategies for Engineered Negligible Senescence (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Strategies for Engineered Negligible Senescence" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
low place
low place
low place
low place
766th place
46th place
low place
low place
low place
low place
low place
low place
9,099th place
590th place

ddw-online.com

doi.org

  • G. Witzany: The viral origins of telomeres and telomerases and their important role in eukaryogenesis and genome maintenance. In: Biosemiotics. Band 1, 2008, S. 191–206, doi:10.1007/s12304-008-9018-0.
  • Coles LS, Young RD: Supercentenarians and transthyretin amyloidosis: the next frontier of human life extension. In: PREVENTATIVE MEDICINE. Band 54, Suppl, 2012, S. s9-s11, doi:10.1016/j.ypmed.2012.03.003, PMID 22579241.
  • D. Joshi, R. Gupta, A. Dubey, A. Shiwalkar, P. Pathak, R. C. Gupta, V. Chauthaiwale, C. Dutt: TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes. In: Journal of cardiovascular pharmacology. Band 54, Nummer 1, Juli 2009, S. 72–81, doi:10.1097/FJC.0b013e3181ac3a34, PMID 19546815.
  • K. P. Chandra, A. Shiwalkar et al.: Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects. In: Clinical drug investigation. Band 29, Nummer 9, 2009, S. 559–575, doi:10.2165/11315260-000000000-00000, PMID 19663519.
  • Ezio Giacobini, Gabriel Gold: Alzheimer disease therapy—moving from amyloid-β to tau. In: Nature Reviews Neurology. Band 9, Nr. 12, Dezember 2013, S. 677–686, doi:10.1038/nrneurol.2013.223.

fiercebiotech.com

fightaging.org

heise.de

nih.gov

ncbi.nlm.nih.gov

  • Szilard L: ON THE NATURE OF THE AGING PROCESS. In: Proc. Natl. Acad. Sci. U.S.A. Band 45, Nr. 1, Januar 1959, S. 30–45, PMID 16590351, PMC 222509 (freier Volltext).
  • Harman D: The biologic clock: the mitochondria? In: J Am Geriatr Soc. Band 20, Nr. 4, April 1972, S. 145–7, PMID 5016631.
  • STREHLER BL, MARK DD, MILDVAN AS: GEE MV: Rate and magnitude of age pigment accumulation in the human myocardium. In: J Gerontol. Band 14, Oktober 1959, S. 430–439, PMID 13835175.
  • MOVAT HZ, MORE RH, HAUST MD: The diffuse intimal thickening of the human aorta with aging. In: Am. J. Pathol. Band 34, Nr. 6, 1958, S. 1023–1031, PMID 13583094, PMC 1934788 (freier Volltext).
  • Monnier VM, Cerami A: Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. In: Science. Band 211, Nr. 4481, Januar 1981, S. 491–493, PMID 6779377.
  • BRODY H: Organization of the cerebral cortex. III. A study of aging in the human cerebral cortex. In: J. Comp. Neurol. Band 102, Nr. 2, April 1955, S. 511–516, PMID 14381544.
  • HAYFLICK L: THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. In: Exp. Cell Res. Band 37, März 1965, S. 614–636, PMID 14315085.
  • Harman D: The biologic clock: the mitochondria? In: J Am Geriatr Soc. Band 20, Nr. 4, April 1972, S. 145–147, PMID 5016631.
  • Coles LS, Young RD: Supercentenarians and transthyretin amyloidosis: the next frontier of human life extension. In: PREVENTATIVE MEDICINE. Band 54, Suppl, 2012, S. s9-s11, doi:10.1016/j.ypmed.2012.03.003, PMID 22579241.
  • D. Joshi, R. Gupta, A. Dubey, A. Shiwalkar, P. Pathak, R. C. Gupta, V. Chauthaiwale, C. Dutt: TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes. In: Journal of cardiovascular pharmacology. Band 54, Nummer 1, Juli 2009, S. 72–81, doi:10.1097/FJC.0b013e3181ac3a34, PMID 19546815.
  • K. P. Chandra, A. Shiwalkar et al.: Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects. In: Clinical drug investigation. Band 29, Nummer 9, 2009, S. 559–575, doi:10.2165/11315260-000000000-00000, PMID 19663519.

sens.org

supercentenarian.com

wissenschaft.de